FDA Enforcement Class II Ongoing

remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use

Recall: Z-1201-2025 · Reported February 26, 2025

Enforcement

Recall Number
Z-1201-2025
Event ID
96312
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Remel, Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 26, 2025
Initiation Date
February 13, 2025
Classification Date
February 20, 2025
Address
12076 Santa Fe Trail Dr, N/A, Lenexa, KS, 66215-3519, United States

Description

remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use

Reason

Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate.

Code Info

UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25

Distribution

US Nationwide distribution.

Quantity

316 units